External Pacemakers Market Report 2026

External Pacemakers Market Overview

• External Pacemakers market size has reached to $1.6 billion in 2025 • Expected to grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Role Of External Pacemakers In Addressing The Growing Burden Of Cardiovascular Disease • Market Trend: Innovative Next-Generation Pacemakers For Advancements In The External Pacemaker Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under External Pacemakers Market?

An external pacemaker is a medical device used to temporarily regulate a patient's heart rate and cardiac output by delivering electrical pulses to the heart via electrodes attached to a patch placed on the chest. These devices are commonly employed to stabilize patients or to provide support during surgical procedures. The main product types of external pacemakers included are single chamber and dual chamber. Single-chamber external pacemakers are devices that utilize one lead to deliver electrical impulses to regulate the heart's rhythm. It is provided for applications such as bradycardia, and acute myocardial infarction. These devices are used by end-users such as hospitals, ambulatory surgical centers, and others.

What Is The External Pacemakers Market Growth Forecast?

The external pacemakers market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising burden of cardiovascular diseases, growing aging population, increasing demand for temporary cardiac pacing solutions, expansion of advanced cardiac care facilities, improving access to emergency and critical care services. Major trends in the forecast period include increasing use of external pacemakers in emergency cardiac care, rising adoption of temporary cardiac pacing in surgical settings, growing demand for portable and user-friendly external pacemakers, increasing preference for dual chamber external pacemakers, rising focus on rapid cardiac stabilization in acute care.

Global External Pacemakers Market Segmentation

1) By Product: Single Chamber, Dual Chamber 2) By Application: Bradycardia, Acute Myocardial Infarction 3) By End-user: Hospitals, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Single Chamber Pacemakers: Unipolar External Pacemakers, Bipolar External Pacemakers 2) By Dual Chamber Pacemakers: Unipolar Dual Chamber Pacemakers, Bipolar Dual Chamber Pacemakers

What Are The Drivers Of The External Pacemakers Market?

The growing incidence of cardiovascular diseases are expected to drive the growth of the external pacemaker market going forward. Cardiovascular disease (CVD) is a class of diseases involving the heart or blood vessels. There is a growing incidence of cardiovascular diseases due to several factors such as sedentary lifestyles, poor dietary habits high in processed foods and sugars, increasing rates of obesity, smoking, high blood pressure, and stress. The external pacemakers are used in cardiovascular diseases to regulate abnormal heart rhythms and improve cardiac function. For instance, in October 2024, according to the Centers for Disease Control and Prevention, is a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths. Therefore, the growing incidence of cardiovascular diseases is expected to propel the growth of the external pacemaker industry. The increasing healthcare expenditure is expected to propel the growth of the external pacemaker market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specific period, typically on a national or institutional level. Investment in healthcare can support research and development efforts in the field of external pacemaker leading to an advancements in technology, improved access to device, and a more comprehensive approach to individuals health and healthcare systems. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the increasing healthcare expenditure is driving the growth of the external pacemaker industry.

Key Players In The Global External Pacemakers Market

Major companies operating in the external pacemakers market are ZOLL Medical Corporation, Shree Pacetronix Ltd, Osypka Medical Inc, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, Biotronik SE & Co KG, LivaNova PLC, MicroPort CRM, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Progetti Medical Equipment Solutions, Instramed Indústria Médico Hospitalar, Corpuls GmbH, Skanray Technologies Ltd, Bexen Cardio, CU Medical Systems Inc, Advanced Instrumentations

Global External Pacemakers Market Trends and Insights

Major companies operating in the external pacemaker market are developing innovative products, such as miniaturized pacemakers, to improve battery life and gain a competitive edge in the market. Miniaturized or leadless pacemakers are small electronic devices implanted in the heart to regulate its rhythm. For instance, in May 2023, Medtronic Plc, an Ireland-based medical device company, received Food and Drug Administration approval for Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. They provide up to 40% more battery life than previous models, with projected median battery life ranging from nearly 16 to 17 years. These devices feature advanced algorithms for automatic AV synchrony programming and higher tracking capability for active patients. Micra pacemakers minimize complications and improve the patient experience with their small size and lack of leads or surgical pockets.

Regional Outlook

North America was the largest region in the external peacemakers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the External Pacemakers Market?

The external pacemakers market consists of sales of MRI-compatible pacemakers and conventional pacemakers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.